Fineline Cube

Follow:
14455 Articles
Policy / Regulatory

China Expands Controlled Substances Catalogue to Include Three Additional Substances

CompanyDrug

Dizal Pharmaceutical’s Golidocitinib Wins NMPA Approval for Relapsed/Refractory PTCL

CompanyDeals

Shanghai Fosun Pharmaceutical Sells Stake in Gland Pharma for USD 211 Million

Company

Jiuzhou Pharmaceutical Shuts Down Two Subsidiaries to Streamline Operations

CompanyDrug

Keymed Biosciences’ CM313 Shows Promise in Treating Immune Thrombocytopenia, NEJM Study Says

CompanyDeals

Xencor Reclaims Rights to Plamotamab After Janssen Halts Development

CompanyDrug

AbbVie’s Skyrizi Secures FDA Approval for Ulcerative Colitis, Expands Treatment Portfolio

CompanyDeals

Genrix Biopharmaceutical and Chongqing Pharmaceutical Group Form Strategic Partnership to Boost Market Launch

Company

AstraZeneca’s Gracell Biotechnologies to Expand Cell Therapy Manufacturing in China

CompanyDrug

NMPA Releases 81st Batch of Reference Drugs for Generic Quality Consistency Evaluation

CompanyDeals

Grifols Completes Sale of 20% Stake in Shanghai RAAS to Haier Group for RMB 12.5 Billion

CompanyDeals

3SBio Secures Long-Term Financing from IFC for Manufacturing and Global Expansion